Amelia Technologies LLC is a rapidly expanding molecular biotechnology company with laboratories and offices located in the Maryland, DC, Virginia biotechnology corridor.
Amelia excels in the development and optimization of molecular diagnostics platforms that measure a range of endpoints associated with DNA damage and repair including general DNA maintenance processes. Currently, Amelia leverages this expertise in four major overlapping areas of research:
Carcinogenesis, aging and associated diseases, genome editing protocols and emerging diagnostics platforms. Our clients and collaborators include academia, industry and government organizations both here in the United States and abroad.